Development of an immunological prognostic Signature in metastatic Patients who were treated with Immune Checkpoint Inhibitors as part of the ST-ICI Study

Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Sun R, Ma H, Fietkau R, Deutsch E, Hecht M, Gaipl U (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Strahlentherapie und Onkologie Urban & Vogel

Publisher: SPRINGER HEIDELBERG

City/Town: HEIDELBERG

Pages Range: S27-S28

Conference Proceedings Title: STRAHLENTHERAPIE UND ONKOLOGIE

Event location: Weisbaden DE

Authors with CRIS profile

Jianguo Zhou Department of Radiation Oncology Anna-Jasmina Donaubauer Department of Radiation Oncology Benjamin Frey Department of Radiation Oncology Ina Becker Department of Radiation Oncology Sandra Rutzner Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie Markus Hecht Department of Radiation Oncology Udo Gaipl Department of Radiation Oncology

Involved external institutions

Institut Gustave-Roussy FR France (FR) Zunyi Medical University CN China (CN)

How to cite

APA:

Zhou, J., Donaubauer, A.-J., Frey, B., Becker, I., Rutzner, S., Sun, R.,... Gaipl, U. (2020). Development of an immunological prognostic Signature in metastatic Patients who were treated with Immune Checkpoint Inhibitors as part of the ST-ICI Study. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S27-S28). Weisbaden, DE: HEIDELBERG: SPRINGER HEIDELBERG.

MLA:

Zhou, Jianguo, et al. "Development of an immunological prognostic Signature in metastatic Patients who were treated with Immune Checkpoint Inhibitors as part of the ST-ICI Study." Proceedings of the 26th Annual Conference of the German-Society-for-Radiation-Oncology (DEGRO), Weisbaden HEIDELBERG: SPRINGER HEIDELBERG, 2020. S27-S28.

BibTeX: Download